Drug intelligence / Profile preview

Lespeflan

Development stage
Unknown
Lead developer
Dalkhimpharm
Modality
Small Molecules
Administration
Oral
01

Overview

Lespeflan is a herbal pharmaceutical product developed and manufactured by the Russian company Dalkhimpharm. It is an extract derived from the shoots of *Lespedeza bicolor*, containing a complex of bioflavonoids that provide hypoazotemic and diuretic effects. The drug is primarily indicated for the treatment of chronic renal failure, particularly in the compensation and early stages of intermittent azotemia. It works by increasing glomerular filtration and facilitating the excretion of nitrogenous metabolic waste products, such as urea and creatinine, from the blood. Lespeflan is typically administered orally as a liquid extract.

Brand names
Lespeflan
Other names
LespephlanumLespedeza bicolor extract
02

Targets

ARG1 (Arginase 1)GATM (L-Arginine:glycine amidinotransferase)

Beyond the preview

Go deeper on Lespeflan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lespeflan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call